top of page
Hero_A_Lipstick_ING_HCP_G13-edited.jpg

best of both worlds

INGREZZA

INGREZZA is a VMAT2 inhibitor medication that treats uncontrollable movements caused by tardive dyskinesia (TD) . TD is an irreversible condition caused by long-term antipsychotic usage and without treatment can worsen over time. The “Best of Both Worlds” campaign highlights how INGREZZA empowers HCPs and patients to treat TD and HD chorea both simply and effectively.

CampaignLineup2.png
Capsule.png
Take-word.png
Control.png

By delivering meaningful results with once-daily dosing, INGREZZA helps doctors help their patients control the uncontrollable movements of TD or HD chorea that can impact everyday lives—because no patient should suffer longer than they have to.

With a duality grounded in INGREZZA being both simple and effective, this campaign boldly establishes INGREZZA as a win-win solution. Finally, HCPs can help their patients take control of their symptoms without their patients having to change their lives around treatment. With both unsurpassed simplicity and robust efficacy, INGREZZA offers control made simple. 

website

websitemockups.png
efficacy_Page_4.jpg
efficacy_Page_6.jpg
efficacy_Page_2.jpg

website videos

While not direct extensions of INGREZZA's Best of Both Worlds campaign, we also created videos for INGREZZA's website to demonstrate the cornerstone sentiments of the campaign, which is INGREZZA's proven simplicity and efficacy across dosing options and pharmacology.

Holding IVA.jpg

interactive visual aid

Interactive visual aids serve as a key resource for drug representatives who visit physicians to educate them about a medication. This information is typically presented via tablet and is designed so the representative can nimbly swipe and click through to areas of interest.

IVA.png
IVA-b.png
IVA-a.png
IVA-c.png
Phone-on-maleuptable.jpg

paid social

Transparentphone.png
Transparentphone.png
  • LinkedIn

© 2025 Alexis O'Neill

bottom of page